Skip to main content
Important safety information

Important
safety information.

Online treatment starts only when a licensed provider determines it is medically appropriate.

Surfbound is not for emergencies. If you are experiencing a medical emergency, call 911 or seek emergency care immediately.

For purposes of this page, "Surfbound," "Surfbound Health," "we," "us," and "our" refer to Open Water Rx LLC, doing business under the Surfbound and Surfbound Health trade names.

Safety
overview.

Provider review is required

Before any prescription decision, you complete a secure online health intake. A licensed provider reviews your health information, medical history, and current medications to determine whether treatment is appropriate for you.

This review is required for every treatment type offered through Surfbound. No prescription is written without a provider evaluation.

Prescriptions are not guaranteed

Completing an online health intake does not guarantee you will receive a prescription. A licensed provider independently determines whether treatment is medically appropriate based on your specific health profile.

If treatment is not prescribed, a provider may guide you toward other options. No charge applies unless your medication is approved.

Compounded medications

Compounded medications are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. They are prescribed only when a licensed provider determines they are medically appropriate for your specific health profile and treatment needs.

Compounded medications are prepared by pharmacies to meet individual patient needs when commercially available options may not be suitable. FDA advises that compounded drugs be used only when a patient’s medical needs cannot be met by an FDA-approved drug. A lower price or lack of insurance does not by itself establish that need, and a provider-approved compounded option is not the same as an FDA-approved medication. Your provider will explain the benefits and risks during your review.

View pharmacy partners →

Emergency warning

Surfbound is not for emergencies. If you are experiencing a medical emergency, call 911 or seek emergency care immediately.

Surfbound provides non-emergency, provider-reviewed treatment options. It is not a substitute for emergency medical care, urgent care, or in-person evaluation when needed.

Weight loss treatment safety overview

Prescription weight-management treatment is not right for everyone, and the risks differ between medicines. A licensed provider reviews your health history, current medicines and risk factors before prescribing.

Tirzepatide: what to know

This subsection applies to tirzepatide. Different prescription weight-management medicines carry different warnings and side effects, so information about one medicine does not automatically apply to another.

FDA-approved tirzepatide products carry a boxed warning. Tirzepatide caused thyroid C-cell tumors in rats. It is not known whether this occurs in humans. Tell your prescriber about a neck lump, persistent hoarseness or trouble swallowing; trouble breathing needs urgent assessment. Do not use tirzepatide if you have a personal or family history of medullary thyroid carcinoma (MTC), have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or have had a serious allergic reaction to tirzepatide or an ingredient in the prescribed product.

Common side effects reported with approved tirzepatide: nausea, diarrhea, vomiting, constipation, abdominal pain, gastroesophageal reflux or heartburn, indigestion, belching, fatigue, injection-site reactions, allergic reactions, hair loss. Digestive symptoms often occur during dose increases and may lessen over time. Severe or persistent symptoms need medical advice.

Serious risks. Important risks include severe digestive problems, dehydration that can lead to kidney injury, gallbladder disease, pancreatitis, serious allergic reactions, and low blood sugar, especially when used with insulin or a sulfonylurea. People with type 2 diabetes should discuss diabetic eye disease and report vision changes. Tell your surgical and anesthesia team that you take tirzepatide before procedures involving general anesthesia or deep sedation, because delayed stomach emptying can increase aspiration risk. Do not decide on a pre-procedure stopping schedule yourself.

When to get medical help

  • Call 911 for trouble breathing, swelling of the face, lips, tongue or throat, collapse, or another life-threatening reaction. Do not wait for a Surfbound support reply.
  • Stop tirzepatide and seek medical help right away for severe, persistent abdominal pain, which may spread to the back, with or without vomiting, or for a suspected serious allergic reaction.
  • Seek prompt medical care if vomiting or diarrhea prevents you from keeping fluids down, you feel faint, or you have signs of dehydration. Upper abdominal pain with fever, yellow skin or eyes, or pale or clay-colored stools also needs prompt assessment. Do not wait for a 24-hour threshold if symptoms are severe.
  • Contact your prescriber promptly about new vision changes, a neck lump, persistent hoarseness or difficulty swallowing. Severe breathing difficulty is an emergency. Follow the low-blood-sugar plan given by your clinician; severe confusion, seizure or loss of consciousness requires emergency help.
  • For mild side effects, follow the instructions for your specific medicine and contact your treating clinician if symptoms persist or worry you. Do not increase or change doses yourself.

Pregnancy and contraception. Tell your prescriber if you are pregnant, could become pregnant, are planning pregnancy, or are breastfeeding. Tirzepatide used for weight management should be stopped when pregnancy is recognized. Weight loss offers no benefit during pregnancy, and tirzepatide may harm the fetus. Contact your prescriber promptly if pregnancy occurs or is suspected. If you use birth control pills, tirzepatide can reduce their effectiveness; the US prescribing information advises switching to a non-oral contraceptive or adding a barrier method such as condoms for 4 weeks after starting and for 4 weeks after every dose increase. The US Zepbound label does not specify a preconception stopping interval, while UK guidance advises stopping tirzepatide at least 1 month before a planned pregnancy; your prescriber should individualize your plan. Detailed guidance: GLP-1 treatment and birth control.

Read the full tirzepatide safety section →

References: Zepbound (tirzepatide) prescribing information, current version and UK guidance on GLP-1 medicines.

Read our detailed guide: GLP-1 Side Effects — What to Expect and How to Manage Them →

Men's health treatment safety overview

ED medications including sildenafil and tadalafil may not be appropriate for everyone. These medications can interact with nitrates and may pose risks for individuals with certain heart conditions, uncontrolled blood pressure, or liver and kidney issues.

Your provider will review your full health history to determine whether these treatments are safe for you. Common side effects may include headache, flushing, and nasal congestion. Discuss all risks with your provider.

Longevity treatment safety overview

Longevity treatments including NAD+ and Sermorelin are prescribed only when a provider determines they may be appropriate. These treatments are not intended to diagnose, treat, cure, or prevent any disease. Results are not guaranteed.

Individual results vary. Your provider will discuss the potential benefits, risks, and limitations of these treatments based on your health profile. Always review all information with your provider before proceeding.

Safety
questions.

No. Every treatment option on this site requires review by a licensed provider. A prescription is written only when the provider determines it is medically appropriate for you based on the health information you provide and applicable standards of care.

No. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are marketed. They are prepared by licensed pharmacies based on a provider’s determination that a compounded option is appropriate for your specific situation. FDA advises that compounded drugs be used only when a patient’s medical needs cannot be met by an FDA-approved drug; a lower price or lack of insurance does not by itself establish that need. Discuss any questions about compounded medications with your provider.

For mild side effects, follow the instructions for your specific medicine and contact your treating clinician if symptoms persist or worry you. Severe symptoms need urgent assessment. For trouble breathing, facial or throat swelling, collapse or a life-threatening reaction, call 911 immediately. Do not wait for a support response. Follow the medicine-specific instructions about stopping treatment; for tirzepatide, stop and seek medical help right away for severe persistent abdominal pain or a suspected serious allergic reaction.

Surfbound is not an emergency service. Do not use this platform for urgent or emergency medical needs. Call 911 or go to the nearest emergency room if you are in a crisis, experiencing severe symptoms, or believe your situation is life-threatening.

You should fully disclose all medical conditions, current medications, allergies, and health history during your online intake. A licensed provider will review your complete health profile and determine whether any treatment is appropriate. Certain conditions or medication combinations may make online treatment unsuitable. The provider makes that call.

Questions before starting?

Visit the support center for answers about treatment, shipping, billing, and safety.

Visit support